Ticker Scorecard - ANNX Basics Company: Annexon, Inc. Common Stock IPO Date: August 1, 2020 Sector: Healthcare Industry: Biotech Market Cap: $299.53M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.65% Avg Daily Range (30 D): $0.13 | 3.49% Avg Daily Range (90 D): $0.14 | 2.80% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 1.23M Avg Daily Volume (90 D): 1.16M Trade Size Avg Trade Size (Sh.): 122 Avg Trade Size (Sh.) (30 D): 117 Avg Trade Size (Sh.) (90 D): 113 Institutional Trades Total Inst.Trades: 608 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.35M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.04M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 266.35K     News Jan 7, 2025 @ 1:00 PM Annexon Biosciences to Present at the 43rd Annual ... Source: N/A Jul 11, 2024 @ 10:10 PM Annexon to Present Additional Phase 2 Data Showing... Source: N/A Jun 28, 2024 @ 1:40 PM Are Medical Stocks Lagging Annexon (ANNX) This Ye... Source: Zacks Equity Research Jun 27, 2024 @ 1:55 PM Here's Why Annexon (ANNX) Is a Great 'Buy the Bott... Source: Zacks Equity Research Jun 25, 2024 @ 9:00 PM Annexon Presented Additional Positive Phase 3 Resu... Source: Annexon Biosciences Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.03 $-.25 $-.23 Diluted EPS $-1.03 $-.25 $-.23 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -117.5M $ -34.82M $ -29.61M Operating Income / Loss $ -131.6M $ -39.44M $ -33.58M Cost of Revenue $ $ $ Net Cash Flow $ -53.62M $ -77.76M $ 5.36M PE Ratio